BioCryst Pharmaceuticals Inc (BCRX) Government Trades - Latest Congressional Stock Transactions
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
top performing (BCRX) trades
Recent BioCryst Pharma (BCRX) Trades by Congress Members
See the most up-to-date BioCryst Pharma trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent BioCryst Pharma trades made by congress members.
Gilbert Ray CisnerosHouse (D-CA) | $1K - $15K | stock | Purchase | Dec 15, 2025 | Nov 13, 2025 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Nov 11, 2023 | Oct 16, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Oct 15, 2023 | Sep 15, 2023 | House |
